An estrogen receptor given to postmenopausal women in combination with estrogen could reduce the risks of hormone therapy by making it more targeted, suggests research in rats.
Source: http://www.betterhumans.com/News/news.aspx?articleID=2003-11-07-3
[Editor: The preceding article was not written by A4M/WHN]
